KAPOSI'S SARCOMA IN TRANSPLANT RECIPIENTS
HUMAN HERPESVIRUS-6 INFECTION IN LIVER TRANSPLANT RECIPIENTS
SALIVARY GLAND TRANSPLANTATION: A CANINE MODEL
IDARUBICIN-ANTI-CD3: A NEW IMMUNOCONJUGATE THAT INDUCES ALLOANTIGEN-SPECIFIC TOLERANCE IN MICE1
ABROGATION OF CHRONIC REJECTION IN A MURINE MODEL OF AORTIC ALLOTRANSPLANTATION BY PRIOR INDUCTION OF DONOR-SPECIFIC TOLERANCE1
EFFECTS OF LEFLUNOMIDE AND DEOXYSPERGUALIN IN THE GUINEA PIG→RAT CARDIAC MODEL OF DELAYED XENOGRAFT REJECTION
LOCAL IMMUNOSUPPRESSION WITH BUDESONIDE AFTER LIVER TRANSPLANTATION IN THE RAT
MODIFICATIONS OF THE CONDITIONING REGIMEN FOR ACHIEVING MIXED CHIMERISM AND DONOR-SPECIFIC TOLERANCE IN CYNOMOLGUS MONKEYS1
INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS IN THE 1990s
CYTOMEGALOVIRUS VIREMIA
NEORAL COMPARED TO SANDIMMUNE IS ASSOCIATED WITH A DECREASE IN HISTOLOGIC SEVERITY OF REJECTION IN PATIENTS UNDERGOING PRIMARY LIVER TRANSPLANTATION1
URINE FLOW CYTOMETRY AS A TOOL TO DIFFERENTIATE ACUTE ALLOGRAFT REJECTION FROM OTHER CAUSES OF ACUTE RENAL GRAFT DYSFUNCTION
EVIDENCE FOR THE PRESENCE OF MULTILINEAGE CHIMERISM AND PROGENITORS OF DONOR DENDRITIC CELLS IN THE PERIPHERAL BLOOD OF BONE MARROW-AUGMENTED ORGAN TRANSPLANT RECIPIENTS1
HEALTH-INDEPENDENT LUNG TRANSPLANTATION INFORMATION OF PARENTS OF CHILDREN WITH CYSTIC FIBROSIS
USE OF AEROSOLIZED COLISTIN SODIUM IN CYSTIC FIBROSIS PATIENTS AWAITING LUNG TRANSPLANTATION
DONOR-SPECIFIC TOLERANCE BY PERIOPERATIVE INTRATHYMIC INJECTION OF BONE MARROW CELLS IN THE RAT CARDIAC ALLOGRAFT MODEL
SUPPRESSION OF ALLOGRAFT RESPONSES INDUCED BY INTERLEUKIN-6, WHICH SELECTIVELY MODULATES INTERFERON-γ BUT NOT INTERLEUKIN-2 PRODUCTION1
A NONVIRAL VECTOR SYSTEM FOR EFFICIENT GENE TRANSFER TO CORNEAL ENDOTHELIAL CELLS VIA MEMBRANE INTEGRINS1
DIFFERENT TREATMENT REGIMENS TO REDUCE MICROBIAL CONTAMINATION OF PURIFIED PORCINE ISLETS OF LANGERHANS1
ARTERITIS AND INCREASED INTRACELLULAR CALCIUM AS A POSSIBLE MECHANISM FOR TACROLIMUS-RELATED CARDIAC TOXICITY IN A PEDIATRIC TRANSPLANT RECIPIENT
CYTOKINE GENE POLYMORPHISM AND HEART TRANSPLANT REJECTION1
A TECHNIQUE FOR MANAGEMENT OF MULTIPLE RENAL ARTERIES AFTER LAPAROSCOPIC DONOR NEPHRECTOMY
LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS IN KIDNEY TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS
SECRETED DONOR-MHC CLASS I ANTIGEN PROLONGS LIVER ALLOGRAFT SURVIVAL AND INHIBITS RECIPIENT ANTI-DONOR CYTOTOXIC T LYMPHOCYTE RESPONSES1
HEPATITIS G VIRUS COINFECTION IN HEPATITIS C VIRUS-INFECTED LIVER TRANSPLANT RECIPIENTS1
SUCCESSFUL SINGLE-LUNG TRANSPLANTATION AFTER PARAQUAT INTOXICATION
IS IT NECESSARY TO USE VENOUS-RIGHT ATRIAL BYPASS IN ORTHOTOPIC LIVER TRANSPLANTATION?
CLINICAL RELEVANCE OF GLUCOCORTICOID PHARMACODYNAMICS IN KIDNEY TRANSPLANTATION
REPLY: CLINICAL RELEVANCE OF GLUCOCORTICOID PHARMACODYNAMICS IN KIDNEY TRANSPLANTATION
ANNOUNCEMENTS